Enphase Energy (ENPH) may be undervalued despite near-term headwinds—see key catalysts, new products, and why a rebound could ...

A big part of WeWork's pitch to potential investors in its IPO is that it has a huge opportunity ahead. Experts say its much smaller than WeWork says.

Management reaffirmed confidence in scaling strategy and future revenue growth, with Bednar stating, "We remain confident in our scaling strategy and believe these investments will drive significant ...

The MarketWatch News Department was not involved in the creation of this content. Vyome's offering is a first-of-its-kind in a broader $20B potential addressable ocular inflammation market VT-1908 ...

VIP Play, Inc. (OTCQB: VIPZ), an AI-first sports entertainment and fan engagement company, pioneering the future of interactive sports experiences, today announced its strategic expansion into the ...

The company expects top line data from the PIK3CA mutant cohort of the VIKTORIA-1 trial in late Q1 or Q2 2026. Sullivan stated, "We expect to complete the submission [to FDA] this quarter." The ...

Enovix Corp (NASDAQ:ENVX) is one of the most promising small-cap industrial stocks under $50. On December 11, George ...

OpenAI is going to buy custom AI processors from Broadcom to power 10 gigawatts of data center capacity. This is a big deal for Broadcom as it could ensure that its outstanding AI revenue growth ...

SKYX Platforms Corp. has announced the issuance of eight new patents, expanding its global patent portfolio to over 100 patents and pending applications. These patents were granted in multiple ...

Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity Vyome’s offering is a first-of-its-kind in a broader $20B ...